Price T Rowe Associates Inc Seres Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 67,392 shares of MCRB stock, worth $62,000. This represents 0.0% of its overall portfolio holdings.

Number of Shares

67,392

Previous 267,398 74.8%

Holding current value

$62,000

Previous $194,000 67.01%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$0.7 - $1.48 $140,004 - $296,008	-200,006 Reduced 74.8%	67,392 $64,000
Q2 2024 Aug 14, 2024	SELL	$0.56 - $1.19 $17,199 - $36,548	-30,713 Reduced 10.3%	267,398 $194,000
Q1 2024 May 15, 2024	SELL	$0.75 - $1.56 $49,154 - $102,240	-65,539 Reduced 18.02%	298,111 $232,000
Q4 2023 Feb 14, 2024	BUY	$0.93 - $2.15 $29,563 - $68,346	31,789 Added 9.58%	363,650 $510,000
Q3 2023 Nov 14, 2023	BUY	$2.33 - $5.07 $40,621 - $88,390	17,434 Added 5.54%	331,861 $791,000
Q2 2023 Aug 14, 2023	SELL	$4.67 - $6.55 $1.26 Million - $1.77 Million	-269,645 Reduced 46.17%	314,427 $1.51 Million
Q1 2023 May 15, 2023	BUY	$4.95 - $6.09 $7,563 - $9,305	1,528 Added 0.26%	584,072 $3.31 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $9.05 $48,624 - $86,454	9,553 Added 1.67%	582,544 $3.26 Million
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $14,987 - $30,830	4,282 Added 0.75%	572,991 $3.68 Million
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.62 $1,350 - $3,810	500 Added 0.09%	568,709 $1.95 Million
Q1 2022 May 16, 2022	BUY	$6.3 - $8.84 $48,163 - $67,581	7,645 Added 1.36%	568,209 $4.05 Million
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $4.82 Million - $9.14 Million	-799,959 Reduced 58.8%	560,564 $4.67 Million
Q3 2021 Nov 15, 2021	SELL	$5.46 - $22.6 $149,145 - $617,341	-27,316 Reduced 1.97%	1,360,523 $9.47 Million
Q2 2021 Aug 16, 2021	SELL	$18.46 - $24.36 $544,625 - $718,693	-29,503 Reduced 2.08%	1,387,839 $33.1 Million
Q1 2021 May 17, 2021	SELL	$17.66 - $28.92 $8.23 Million - $13.5 Million	-465,918 Reduced 24.74%	1,417,342 $29.2 Million
Q4 2020 Feb 16, 2021	BUY	$23.25 - $37.73 $43.8 Million - $71.1 Million	1,883,260 New	1,883,260 $46.1 Million

Others Institutions Holding MCRB

# of Institutions

Shares Held

40.5M

Call Options Held

304K

Put Options Held

471K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Seres Therapeutics, Inc. Transaction History